Monoclonal Antibody CD133–2 (AC141) Against Hematopoietic Stem Cell Antigen CD133 Shows Crossreactivity With Cytokeratin 18

Journal of Histochemistry and Cytochemistry - United States
doi 10.1177/002215540205000814
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Monoclonal Antibodies 13A4 and AC133 Do Not Recognize the Canine Ortholog of Mouse and Human Stem Cell Antigen Prominin-1 (CD133)

PLoS ONE
Multidisciplinary
2016English

Percoll Gradient Optimization for Blood CD133+ Stem Cell Recovery

Stem Cell Discovery
2014English

CD133 Expression in Circulating Hematopoietic Progenitor Cells

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2018English

An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity Against Colorectal Cancer

Cancers
Cancer ResearchOncology
2019English

CD133 Marks a Stem Cell Population That Drives Human Primary Myelofibrosis

Haematologica
Hematology
2015English

G-Protein-Signaling Modulator 2 Expression and Role in a CD133+ Pancreatic Cancer Stem Cell Subset

OncoTargets and Therapy
OncologyPharmacology
2019English

CD133 in Breast Cancer Cells: More Than a Stem Cell Marker

Journal of Oncology
Oncology
2019English

Rapid Reconstitution of Dendritic Cells After Allogeneic Transplantation of CD133+ Selected Hematopoietic Stem Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

The Stem Cell Marker CD133 Associates With Enhanced Colony Formation and Cell Motility in Colorectal Cancer

PLoS ONE
Multidisciplinary
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy